PrP^Sc-specific antibodies do not induce prion disease or misfolding of PrP^C in highly susceptible Tga20 mice

References

• Pan KM, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, Mehlhorn I, Huang Z, Fletterick RJ, Cohen FE, et al. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A 1993; 90:10962 - 6; http://dx.doi.org/10.1073/pnas.90.23.10962; PMID: 7902575
   PubMed Web of Science ®Google Scholar
• Ward HJ, Everington D, Cousens SN, Smith-Bathgate B, Leitch M, Cooper S, Heath C, Knight RS, Smith PG, Will RG. Risk factors for variant Creutzfeldt-Jakob disease: a case-control study. Ann Neurol 2006; 59:111 - 20; http://dx.doi.org/10.1002/ana.20708; PMID: 16287153
   PubMed Web of Science ®Google Scholar
• Hamaguchi T, Noguchi-Shinohara M, Nozaki I, Nakamura Y, Sato T, Kitamoto T, Mizusawa H, Yamada M. The risk of iatrogenic Creutzfeldt-Jakob disease through medical and surgical procedures. Neuropathology 2009; 29:625 - 31; http://dx.doi.org/10.1111/j.1440-1789.2009.01023.x; PMID: 19659942
   PubMed Web of Science ®Google Scholar
• Daude N. Prion diseases and the spleen. Viral Immunol 2004; 17:334 - 49; http://dx.doi.org/10.1089/vim.2004.17.334; PMID: 15357900
   PubMed Web of Science ®Google Scholar
• Kretzschmar H, Tatzelt J. Prion disease: a tale of folds and strains. Brain Pathol 2013; 23:321 - 32; http://dx.doi.org/10.1111/bpa.12045; PMID: 23587138
   PubMed Web of Science ®Google Scholar
• Béringue V, Vilotte JL, Laude H. Prion agent diversity and species barrier. Vet Res 2008; 39:47; http://dx.doi.org/10.1051/vetres:2008024; PMID: 18519020
   PubMed Web of Science ®Google Scholar
• Williams ES, Miller MW. Transmissible spongiform encephalopathies in non-domestic animals: origin, transmission and risk factors. Rev Sci Tech 2003; 22:145 - 56; PMID: 12793777
   PubMed Web of Science ®Google Scholar
• Holmes D. vCJD remains an enigma as UK deaths fall to zero for 2012. Lancet Infect Dis 2012; 12:914 - 5; http://dx.doi.org/10.1016/S1473-3099(12)70304-3; PMID: 23316491
   PubMed Web of Science ®Google Scholar
• Saunders SE, Bartelt-Hunt SL, Bartz JC. Occurrence, transmission, and zoonotic potential of chronic wasting disease. Emerg Infect Dis 2012; 18:369 - 76; http://dx.doi.org/10.3201/eid1803.110685; PMID: 22377159
   PubMed Web of Science ®Google Scholar
• Gilch S, Chitoor N, Taguchi Y, Stuart M, Jewell JE, Schätzl HM. Chronic wasting disease. Top Curr Chem 2011; 305:51 - 77; http://dx.doi.org/10.1007/128_2011_159; PMID: 21598099
   PubMed Web of Science ®Google Scholar
• Li L, Napper S, Cashman NR. Immunotherapy for prion diseases: opportunities and obstacles. Immunotherapy 2010; 2:269 - 82; http://dx.doi.org/10.2217/imt.10.3; PMID: 20635933
   PubMed Web of Science ®Google Scholar
• White AR, Collins SJ, Maher F, Jobling MF, Stewart LR, Thyer JM, Beyreuther K, Masters CL, Cappai R. Prion protein-deficient neurons reveal lower glutathione reductase activity and increased susceptibility to hydrogen peroxide toxicity. Am J Pathol 1999; 155:1723 - 30; http://dx.doi.org/10.1016/S0002-9440(10)65487-9; PMID: 10550328
   PubMed Web of Science ®Google Scholar
• Sonati T, Reimann RR, Falsig J, Baral PK, O’Connor T, Hornemann S, Yaganoglu S, Li B, Herrmann US, Wieland B, et al. The toxicity of antiprion antibodies is mediated by the flexible tail of the prion protein. Nature 2013; 501:102 - 6; http://dx.doi.org/10.1038/nature12402; PMID: 23903654
   PubMed Web of Science ®Google Scholar
• Cashman NR, Loertscher R, Nalbantoglu J, Shaw I, Kascsak RJ, Bolton DC, Bendheim PE. Cellular isoform of the scrapie agent protein participates in lymphocyte activation. Cell 1990; 61:185 - 92; http://dx.doi.org/10.1016/0092-8674(90)90225-4; PMID: 1969332
   PubMed Web of Science ®Google Scholar
• Mouillet-Richard S, Ermonval M, Chebassier C, Laplanche JL, Lehmann S, Launay JM, Kellermann O. Signal transduction through prion protein. Science 2000; 289:1925 - 8; http://dx.doi.org/10.1126/science.289.5486.1925; PMID: 10988071
   PubMed Web of Science ®Google Scholar
• Schneider B, Pietri M, Pradines E, Loubet D, Launay JM, Kellermann O, Mouillet-Richard S. Understanding the neurospecificity of Prion protein signaling. Front Biosci (Landmark Ed) 2011; 16:169 - 86; http://dx.doi.org/10.2741/3682; PMID: 21196165
   PubMed Web of Science ®Google Scholar
• Arsenault RJ, Li Y, Potter A, Griebel PJ, Kusalik A, Napper S. Induction of ligand-specific PrP (C) signaling in human neuronal cells. Prion 2012; 6:477 - 88; http://dx.doi.org/10.4161/pri.21914; PMID: 22918447
   PubMed Web of Science ®Google Scholar
• Paramithiotis E, Pinard M, Lawton T, LaBoissiere S, Leathers VL, Zou WQ, Estey LA, Lamontagne J, Lehto MT, Kondejewski LH, et al. A prion protein epitope selective for the pathologically misfolded conformation. Nat Med 2003; 9:893 - 9; http://dx.doi.org/10.1038/nm883; PMID: 12778138
   PubMed Web of Science ®Google Scholar
• Hedlin PD, Cashman NR, Li L, Gupta J, Babiuk LA, Potter AA, Griebel P, Napper S. Design and delivery of a cryptic PrP(C) epitope for induction of PrP(Sc)-specific antibody responses. Vaccine 2010; 28:981 - 8; http://dx.doi.org/10.1016/j.vaccine.2009.10.134; PMID: 19925901
   PubMed Web of Science ®Google Scholar
• Li L, Guest W, Huang A, Plotkin SS, Cashman NR. Immunological mimicry of PrPC-PrPSc interactions: antibody-induced PrP misfolding. Protein Eng Des Sel 2009; 22:523 - 9; http://dx.doi.org/10.1093/protein/gzp038; PMID: 19602568
   PubMed Web of Science ®Google Scholar
• Kurt TD, Seelig DM, Schneider JR, Johnson CJ, Telling GC, Heisey DM, Hoover EA. Alteration of the chronic wasting disease species barrier by in vitro prion amplification. J Virol 2011; 85:8528 - 37; http://dx.doi.org/10.1128/JVI.00809-11; PMID: 21697475
   PubMed Web of Science ®Google Scholar
• Barria MA, Telling GC, Gambetti P, Mastrianni JA, Soto C. Generation of a new form of human PrP(Sc) in vitro by interspecies transmission from cervid prions. J Biol Chem 2011; 286:7490 - 5; http://dx.doi.org/10.1074/jbc.M110.198465; PMID: 21209079
   PubMed Web of Science ®Google Scholar
• Legname G, Nguyen HO, Peretz D, Cohen FE, DeArmond SJ, Prusiner SB. Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc Natl Acad Sci U S A 2006; 103:19105 - 10; http://dx.doi.org/10.1073/pnas.0608970103; PMID: 17142317
   PubMed Web of Science ®Google Scholar
• Béringue V, Herzog L, Jaumain E, Reine F, Sibille P, Le Dur A, Vilotte JL, Laude H. Facilitated cross-species transmission of prions in extraneural tissue. Science 2012; 335:472 - 5; http://dx.doi.org/10.1126/science.1215659; PMID: 22282814
   PubMed Web of Science ®Google Scholar
• Madampage CA, Maattanen P, Marciniuk K, Brownlie R, Andrievskaia O, Potter A, Cashman N, Lee JS, Napper S. Binding of bovine T194A PrP (C) by PrP (Sc) -specific antibodies: Potential implications for immunotherapy of familial prion diseases. Prion 2013; 7:301 - 11; http://dx.doi.org/10.4161/pri.25148; PMID: 23787697
   PubMed Web of Science ®Google Scholar
• Race RE, Ernst D. Detection of proteinase K-resistant prion protein and infectivity in mouse spleen by 2 weeks after scrapie agent inoculation. J Gen Virol 1992; 73:3319 - 23; http://dx.doi.org/10.1099/0022-1317-73-12-3319; PMID: 1361522
   PubMed Web of Science ®Google Scholar
• Fischer M, Rülicke T, Raeber A, Sailer A, Moser M, Oesch B, Brandner S, Aguzzi A, Weissmann C. Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J 1996; 15:1255 - 64; PMID: 8635458
   PubMed Web of Science ®Google Scholar
• Roettger Y, Du Y, Bacher M, Zerr I, Dodel R, Bach JP. Immunotherapy in prion disease. Nat Rev Neurol 2013; 9:98 - 105; http://dx.doi.org/10.1038/nrneurol.2012.258; PMID: 23247613
   PubMed Web of Science ®Google Scholar